Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Zac Mirecki displays on six years of survivorship, sharing how his AML journey taught him to prioritize self-care, search connection, and assist others...
Multidisciplinary care, a collaborative strategy the place varied healthcare disciplines come collectively, is important for treating these with prostate most cancers.Multidisciplinary care is...
